Phillips Andrew John bought ELVN
February 13, 2024 · Form 4 insider transaction
Phillips Andrew John bought 16,835 shares of Enliven Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
16,835
Price
$0.00
Total value
N/A
InsiderPhillips Andrew John
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after16,835
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.